https://www.avient.com/sites/default/files/2024-10/Avient_CodeConduct_2024_CZ2.pdf
KODEX CHOVÁNÍ | 4
POCTIVOST NA
INTEGRITA PŘI NAŠEM
SPOLEČENSKÁ
https://secure.ethicspoint.com/domain/media/en/gui/49178/index.html
Řešení otázek a hlášení nedodržování
předpisů
Náš Kodex chování poskytuje pokyny, jak nakládat s problémy, které se
mohou v práci objevit, a poskytuje pomoc se správným rozhodnutím.
KODEX CHOVÁNÍ | 24
POCTIVOST NA
INTEGRITA PŘI NAŠEM
SPOLEČENSKÁ
mailto:https://secure.ethicspoint.com/domain/media/en/gui/49178/index.html?
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520-%2520Investor%2520Day%25205-18-15.pdf
Garratt
President, Performance Products and Solutions
PolyOne Corporation Page 48
2014 Revenue by
Industry Segment
2014 Revenues:
$0.8 Billion
At a Glance
Performance Products & Solutions
80%
14%
Latin
America
4%
Building &
33%
Electrical &
1%
11%
5% Transportation
18% Wire & Cable
16%
PolyOne Corporation Page 49
What We Have Delivered
4.3%
6.3%
7.2%
7.7%
2011 2012 2013 2014
Operating Margin
$28
$39
$56
$63
2011 2012 2013 2014
Operating Income ($M) •Relentless focus on
portfolio mix optimization
•Lean Six Sigma drives
operational excellence
• Innovating in new markets
such as healthcare
•Expanding presence in
Mexico and China
Performance Products & Solutions
PolyOne Corporation Page 50
$96
$109
2006* 2014
To Value
Gross Margin
($ in millions)
+13%
1,431
1,124
2006* 2014
From Volume…
(lbs in millions)
-21%
Performance Products & Solutions
*2006 = Near peak housing
PolyOne Corporation Page 51
Accelerating Growth
Market Growth/
Megatrends
Innovation
Collaboration
Geographic
Expansion
Performance Products & Solutions
PolyOne Corporation Page 52
Who We Are Growing With
Performance Products & Solutions
PolyOne Corporation Page 53
Geographic Growth Opportunities
Mexico represents growth,
spurred by:
• Robust demand in Automotive
• Re-shoring from Asia
• PolyOne collaboration
China is a $2B PVC market;
2nd largest in the world:
• A new tax license enables
domestic (vs. export) business
• We have expanded capacity
• We are investing in capability
Performance Products & Solutions
PolyOne Corporation Page 54
Addressable Market
($ millions) $300 $150 $200
Innovation Pipeline Potential
Performance Products & Solutions
Prototype Frame
Opportunity
Scale-up & Test
Market
Build
Business Case
Commercial
Launch
Phase 1 Phase 2 Phase 3 Phase 4 Phase 5
0
2
0
1
0
3
0 1 1
1
5
3
1
1
1
Breakthrough
Platform
Derivative
PolyOne Corporation Page 55
Megatrends Aligned with Key End Markets
Increasing
Energy
Efficiency
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
Performance Products & Solutions
PolyOne Corporation Page 56
Healthcare Solutions
LED Lighting
Key Initiatives
Eco-Conscious
Solutions
$25M
Revenue
potential
$30M
Revenue
potential
$60M
Revenue
Potential
Performance Products & Solutions
PolyOne Corporation Page 57
Platinum Vision
4.3%
6.3%
7.2% 7.7%
10-12%
2011 2012 2013 2014 2020
Platinum
Vision
World Class Operating Margin
Accelerating Growth
Performance Products & Solutions
Market Growth/
Megatrends
Innovation Collaboration Geographic
Expansion
PolyOne Corporation Page 58
Summary
• Business evolution from volume to value
• Business is at an inflection point
• Growth will be driven by:
Economic & Megatrend alignment
Innovation
Collaboration across PolyOne
Geographic sales expansion in China and Mexico
Performance Products & Solutions
PolyOne Corporation Page 59
PolyOne Distribution
Mark Crist
President, Distribution
PolyOne Corporation Page 60
At a Glance
PolyOne Distribution
15%
52%
2006 2014
Key Suppliers 2014 Revenues: $1.1 Billion
ROIC
Building &
13%
Electrical &
23%
15%
4%
25%
http://www.avient.com/Pages/VariationRoot.aspx
PolyOne Corporation Page 61
What We Do
Processing Expertise
World-Class Supply Chain
Deep Customer Relationships
Market Consultation
Right the First Time… Every Time
PolyOne Corporation Page 62
What We Have Delivered
2.6%
3.5%
4.6%
6.4% 6.1%
2006 2008 2010 2012 2014
Operating Margin
$19
$28
$42
$66 $68
2006 2008 2010 2012 2014
Operating Income ($M) • World class supplier
line card
• Differentiating with
service and operational
excellence
• Key portfolio additions
with DuPont, Bayer
and Ineos
• Value based selling
and discipline
PolyOne Distribution
PolyOne Corporation Page 63
Accelerating Growth
PolyOne Distribution
Market Growth/
Megatrends
Commercial
Investment
Cross-Selling &
Collaboration
Growth in
Targeted Areas
PolyOne Corporation Page 64
Who We Are Growing With
PolyOne Distribution
PolyOne Corporation Page 65
Megatrends Aligned with Key End Markets
Increasing
Energy
Efficiency
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
PolyOne Distribution
PolyOne Corporation Page 66
Geographic Growth Opportunities
• Currently 10% of POD’s revenue is
generated from Mexico
• Existing business is served “from
the border”
• New Mexico district & warehouse
will drive transportation growth in
Central Mexico
• Expansion in China resulted from
growing with our NA HC customers
• Investing in sales deployments
• Localizing supply
• Gaining Share
PolyOne Distribution
PolyOne Corporation Page 67
Going Beyond Distribution
WeatherTech® –
Polymer BumpStep®
BEDRUG™ – Tri-fold
Truck Bed Cover
CeQur PaQ – Type 2
Insulin Delivery Device
PolyOne Distribution
PolyOne Corporation Page 68
Platinum Vision
2.6%
4.6%
6.1%
6.5 - 7.5%
2006 2010 2014 2020
Platinum
Vision
World Class Distribution Margin
Accelerating Growth
PolyOne Distribution
Market Growth/
Megatrends
Commercial Investment Cross-Selling &
Collaboration
Growth in
Targeted Areas
PolyOne Corporation Page 69
Summary
• Motivated and well trained POD sellers
making the calls / collaborating with other
PolyOne businesses
• Representing a world class supplier line card
• Delighted customers and
suppliers who choose us
to represent them
PolyOne Distribution
PolyOne Corporation Page 70
Financial Highlights
Bradley C.
Senior management uses operating income excluding special items, adjusted EPS, and working
capital to assess performance and allocate resources because senior management believes that these measures are useful in
understanding current profitability levels and that current levels may serve as a base for future performance.
https://www.avient.com/sites/default/files/2022-08/Avient Candidates Data Privacy Notice Final - German.pdf
Beachten Sie bitte, dass alle Änderungen an Ihrem Profil
Auswirkungen auf Ihre aktuelle(n) Bewerbung(en) haben können.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520Sidoti%2520wNonGAAP%2520Rec.pdf
Senior management uses adjusted operating income, adjusted
EPS, and working capital to assess performance and allocate resources because senior management believes
that these measures are useful in understanding current profitability levels and that current levels may serve as
a base for future performance.
https://www.avient.com/sites/default/files/resources/Novel_Thermoplastic_elastomers_for_overmolding_applications.pdf
Jiren Gu and Krishna Venkataswamy, “Block Copolymer Compositions for Overmolding any TPE,US patent
filed , March 2004
Figure1.
https://www.avient.com/sites/default/files/resources/POL%2520KeyBanc%2520IR%2520Presentation%2520w%2520non-GAAP%252009%252010%25202013.pdf
Senior management uses adjusted operating income, adjusted EPS, and working
capital to assess performance and allocate resources because senior management believes that these measures are useful in
understanding current profitability levels and that current levels may serve as a base for future performance.
https://www.avient.com/sites/default/files/2024-10/Avient CDP Climate Change %26 Water Submission 20241001.pdf
https://www.cdp.net/en/info/terms-and-conditions/terms-of-disclosure/corporate-questionnaire
1
Contents
2
C1.
Not only does this give us insight into our current rating, but
it also helps us better understand potential areas of improvement.
DEFRA and US EPA EF Hub are used for
emission factors.
https://www.avient.com/sites/default/files/2022-05/DOC 1879.pdf
If any further information beyond included content is needed, feel free to
contact us.
https://www.avient.com/sites/default/files/resources/Innovation_Day_-_May_2014_0.pdf
Richardson
Executive Vice President, Chief Financial Officer
PolyOne Corporation Page 15
Track Record of Accelerated Growth
Total Revenue Adjusted EPS Adjusted EBITDA
$2,061
$2,506
$2,709
$2,861
$3,771
2009 2010 2011 2012 2013
($ in millions, except EPS )
$105
$179
$202
$255
$344
2009 2010 2011 2012 2013
$0.13
$0.68
$0.82
$1.00
$1.31
2009 2010 2011 2012 2013
PolyOne Corporation Page 16
$0.31
$0.44
$0.20
$0.30
$0.40
Q1 2013 Q1 2014
Adjusted EPS
$42
$60
$20
$40
$60
Q1 2013 Q1 2014
Specialty Operating Income
($ millions)
Q1 2014 Financial Highlights
Growth momentum accelerates
driven by specialty platform
Specialty segments and
Distribution achieve record results
All segments increase operating
income compared to prior year
Revenue grew 25% versus
Q1 2013
+43%
+42%
$57
$79
$30
$60
$90
Q1 2013 Q1 2014
Adjusted Operating Income
($ millions)
+39%
PolyOne Corporation Page 17
Commitment to Operational Excellence
81%
96%
2006 2013
16.2%
10.9%
2006 2013
On-Time Delivery
Working Capital % of Sales
5.0%
31.0%
2006 2013
Percent of Associates Trained in LSS
Three consecutive years – CFO Magazine
Best Working Capital Management
Program in the chemical industry
World’s Best Business
Process Excellence
Program in 2012*
95 certified Black Belts
211 certified Green Belts
422 Project Leaders
World’s Best “Start-up
Program” for Lean Six Sigma
Deployment in 2009*
*Both awards received from International Quality and Productivity Center
PolyOne Corporation Page 18
Debt Maturities & Pension Funding – 3/31/14
Net Debt / EBITDA* = 1.9x
$48
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of March 31, 2014
($ millions)
Coupon Rates: 7.500% 7.375% 5.250%
*TTM 12/31/2013
** includes US-qualified pension plans only
60%
100%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 2014
Pension Funding**
As of March 31, 2014
PolyOne Corporation Page 19
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
$0.16
$0.20
$0.24
$0.32
$0.10
$0.20
$0.30
$0.40
2011 2012 2013 2014
Annual Dividend
Expanding our sales, marketing,
and technical capabilities
Targets that expand our:
• Specialty offerings
• End market presence
• Geographic footprint
• Operating Margin
Synergy opportunities
Adjacent material solutions
Repurchased 1.4 million shares in
Q1 2014
Repurchased 6.4 million
shares since April 2013
13.6 million shares are
available for
repurchase under the
current authorization
Organic
Growth
Acquisitions
Share
Repurchases
Dividends
Investing in operational and
LSS initiatives (including
synergy capture)
Manufacturing alignment
PolyOne Corporation Page 20
3.07 3.05
1.81
1.45
1.82
1.54
0.85
3.15
1.17
1.69
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
4.00
0.91
PolyOne
Valuation Aspirations
PEG Ratio Comparison
Represents $38 of
share price upside
Avg = 1.96
PolyOne Corporation Page 21
Innovating for the Future
Dr.
https://www.avient.com/sites/default/files/2022-04/Asia SEM Healthcare Product Selection Guide_CN.pdf
Versaflex™ OM3060
PP包覆成型 硬度 法规 灭菌 特性
28A 环氧乙烷 柔软的半透明材料,粘性好
43A 环氧乙烷 高度可着色的解决方案,
粘性好,不易压缩变形
42A/ 50A 环氧乙烷 透明的耐高温级材料;
ABS、PC可粘合
60A 环氧乙烷/蒸汽 弹性高,不易压缩变形
20A-90A 环氧乙烷 用途广泛,无填充
ABS,PC包覆成型 硬度 法规 灭菌 特性
40A USP VI级,ISO 10993 环氧乙烷 半透明
60A USP VI级,ISO 10993 环氧乙烷 透明
VERSAFLEX™ CL与DYNAFLEX™
包覆成型,符合人体
工程学设计
触感柔软,有利于形成良好的表面
有多种颜色效果和纹理可供选择
提高抓握力、缓冲力和舒适度
提高性能表现,如密封性能、减震、隔氧、
耐刮擦和耐磨性能
降低装配成本,加工性能良好
可牢固包覆于各种基材上
血糖仪
医用工具包覆成型
注射笔
分析仪器
Dynaflex™ G2706
Dynaflex™ G2711
Versaflex™
CL2242 & CL2250
Versaflex™ G2705 N
Versaflex™ HC3810
Versaflex™ OM1040
US食品接触
USP VI级,ISO 10993
材料描述 硬度 法规 灭菌 特性
45A USP VI级
55A USP VI级
70A USP VI级
43A 环氧乙烷
34A
USP VI级,
ISO 10993-4/5
FDA,USP VI级,
ISO 10993
57A
挤出级,耐高温
再密封,压缩变形性能提高
摩擦低
Versalloy™ HC 9210-55N
Versalloy™ HC 9210-70N
Versalloy™ HC 9220-43N
Versaflex™ HC 2110-35N
Versaflex™ HC 2110-57B FDA,USP VI级,
ISO 10993
环氧乙烷 加工性能良好,表面光洁、美观
环氧乙烷
环氧乙烷
加工性能良好,表面光洁、美观
加工性能良好,表面光洁、美观
高压灭菌、环氧乙烷、
高压灭菌、环氧乙烷、
VERSALLOY™ HC与VERSAFLEX™ HC
密封和再密封
柔软的橡胶质感
无抽芯,静态推塞被刺穿后再密封性良好
满足动态密封的低摩擦系数要求
可萃取物含量低
适合在聚烯烃上包覆成型
密封和密封隔膜
密封件和卫生垫圈
注射器推塞和塞头
Versalloy™ HC 9210-45N
材料描述 硬度 法规 灭菌 特性
65A/ 75A/ 84A
54A
67A
高压灭菌器
透明度高,不含增塑剂,无油
工作温度高,可高温灭菌
环氧乙烷、辐射灭菌
Versaflex™ HC MT555
Versaflex™ HC BT218
VERSAFLEX™ CL与DYNAFLEX™
高透明度级,不含增塑剂
无色透明级,配方不含邻苯二甲酸酯增塑剂
符合医疗法规USP VI级和ISO 10993-4、5的
要求
食品接触用并符合FDA标准
可高压灭菌和辐射灭菌
可萃取物含量低
透明度高(雾度50 4.1, 100 4.5, 100 4, 70 6, 70
拉伸模量(MPa) 2200 2700 2600 2350 1820 1820
挠曲强度(MPa) 80 90 104 86 68 68
挠曲模量(MPa) 2500 2700 2500 2300 1980 1590
HDT:0.45、1.8(MPa) 110, 80 90, 80 100, 89 123, 100 123, 64 100, 70
UL-94等级,3.0mm 5VA V-0 5VA V-0 HB V-0
UL-94等级,1.5mm V-0 V-0 5VB V-0 HB V-0
UL-94等级,0.75mm V-1 V-2 V-0 无 无 V-2
竞争材料对比
医疗保健特种工程聚合物配方
TRILLIANT™ HC热塑性塑料
Trilliant™ HC高性能热塑性弹性体系列配方是专为应对日趋严苛的医疗器械和设备而开发的。